
Eli Lilly’s diagnostic radiopharmaceutical Amyvid has been approved in Europe to assess whether patients have Alzheimer’s disease. Amyvid (Florbetapir F …

Bristol-Myers Squibb has appointed Mike Burgess as senior vice president, Discovery Medicine and Clinical Pharmacology. He will report to Francis …

Amgen has unveiled plans to construct a new manufacturing plant in Singapore, its first production facility in Asia. The biotechnology …

Biogen Idec and Elan have applied to the FDA and EMA to expand Tysabri’s use in patients with relapsing forms …
An influential group of MPs has hit out at inactivity over moves towards value-based pricing (VBP), saying that the issue …

Packaging firm Rieke Dispensing has appointed Nicolas Lemaigre-Voreaux as its European Sales director to spearhead the company’s growth programme. Lemaigre-Voreaux …

A new global digital practice, go digital health, has been launched by Virgo Health and GolinHarris. The team brings together …

The European Medicines Agency has issued draft guidance to help drug manufacturers avoid cross-contamination of products made in shared facilities. …

Bayer has been found not guilty of making multiple breaches of the ABPI Code of Practice following an anonymous complaint …

The Scottish government is launching a £21 million fund in March to meet the costs of patients who require orphan …
Strategic pharma marketing consultancy firm The MSI Consultancy has appointed David Watson as a senior consultant, specialising in channel strategy. …
Private equity firm American Capital has said it will pay $212 million to buy out Cambridge Major Laboratories (CML), a …

One of the strange paradoxes of our industry is that we have a very large number of new medicines in …

AstraZeneca has taken its most dramatic steps yet to arrest decline, with chief executive Pascal Soriot axeing two senior positions …

Vice president of Market Access, Health Policy & Medical Affairs at Sanofi Pasteur MSD Andrea Rappagliosi has been appointed president …
Boehringer Ingelheim has entered a five-year tie-up with a UK biotech company which specialises in helping research into personalised medicines. …

Patient groups have welcomed NICE’s new draft guideline recommending the use of preventive treatments in women who have a family …
Mitsubishi Chemical has agreed to buy Qualicaps from US private equity company Carlyle Group in the latest round of M&A …

Janssen is celebrating the European Commission’s decision to extend the licence for its prostate cancer treatment Zytiga. The once-daily pill …
Facility news from Orient Europharma/NanoCarrier, Catalent and China Biologic, plus new contracts for Emerson Process Management and Biotest Pharma.